Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PET/CT”

1,883 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,883 results

Not applicableLooking for participantsNCT05324332
What this trial is testing

68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Peking Union Medical College Hospital 50
Not applicableLooking for participantsNCT06770478
What this trial is testing

Evaluate the Diagnostic Efficacy of 68Ga- MY6349 PET/CT in Patients With Tumours

Who this might be right for
Tumour of Epithelial Origin68Ga-MY6349
Xijing Hospital 40
Early research (Phase 1)Active Not RecruitingNCT02608216
What this trial is testing

[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmMetastatic Breast CancerRb+ Breast Cancer
University of Pennsylvania 20
Not applicableUnknownNCT05165602
What this trial is testing

Evaluation of HER2-targeted Therapy for Gastric Cancer and Establishment and Verification of Monitoring System

Who this might be right for
HER2 Positive Gastric Cancer
Peking University 30
Not applicableEnrolling By InvitationNCT03755245
What this trial is testing

Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary Sarcoidosis

Who this might be right for
Healthy SubjectsRheumatoid ArthritisVasculitis+1 more
Turku University Hospital 26
Not applicableUnknownNCT02733887
What this trial is testing

MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma

Who this might be right for
Lymphoma
Guangxi Medical University 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT07059832
What this trial is testing

Application of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography (PET/CT) in Tumors

Who this might be right for
Cancer
First Hospital of China Medical University 30
Not applicableEnded earlyNCT05299632
What this trial is testing

F-18 PSMA for Localization of Parathyroid Adenoma

Who this might be right for
Hyperparathyroidism
Emory University 3
Large-scale testing (Phase 3)WithdrawnNCT01762592
What this trial is testing

REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT

Who this might be right for
Renal Cell CarcinomaKidney Cancer
Heidelberg Pharma AG
Testing effectiveness (Phase 2)Active Not RecruitingNCT03314636
What this trial is testing

Intensified Treatment With Carfilzomib in Myeloma Patients Still PET-positive After First Line Treatment.

Who this might be right for
Myeloma
Oslo University Hospital 53
Post-approval studies (Phase 4)Study completedNCT02374021
What this trial is testing

Treatments Against RA and Effect on FDG-PET/CT

Who this might be right for
Arthritis, Rheumatoid
Brigham and Women's Hospital 159
Not applicableNot Yet RecruitingNCT06700564
What this trial is testing

The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/CT and Enhanced MRI in Hepatic Malignancies

Who this might be right for
Hepatoma
Shanghai East Hospital 60
Very early researchActive Not RecruitingNCT05111509
What this trial is testing

A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent

Who this might be right for
Neuroendocrine Tumor Grade 2Neuroendocrine Tumor Grade 1
Yusuf Menda 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06595563
What this trial is testing

HER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients With Advanced HER2-positive Breast Cancer

Who this might be right for
HER2-positive Metastatic Breast CancerHER2-positive Advanced Breast Cancer
Jules Bordet Institute 87
Not applicableStudy completedNCT01963221
What this trial is testing

Relationship Between Thoracic Aortic Structure Assessed B PET/CT Scan and Arterial Stiffness in Elderly Patients

Who this might be right for
AgingInflammation
Central Hospital, Nancy, France 30
Not applicableStudy completedNCT02385604
What this trial is testing

The Predictive Value of CT-PET in Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
St. James's Hospital, Ireland 250
Not applicableUnknownNCT00984191
What this trial is testing

Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid

Who this might be right for
Papillary Thyroid Cancer
Chulalongkorn University 15
Testing effectiveness (Phase 2)Study completedNCT02448225
What this trial is testing

18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules

Who this might be right for
Lung CarcinomaSolitary Pulmonary NoduleCigarette Smoking Behavior
Vanderbilt-Ingram Cancer Center 46
Testing effectiveness (Phase 2)Study completedNCT02888080
What this trial is testing

Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary Sarcoidosis

Who this might be right for
Pulmonary Sarcoidosis
Novartis Pharmaceuticals 40
Not applicableStudy completedNCT03561025
What this trial is testing

Diagnostic Potential of PET/MRI in Cardiac Sarcoidosis

Who this might be right for
SarcoidosisCardiomyopathies
St. Olavs Hospital 33
Load More Results